This is a prospective, single arm study, consisting of 20 women with abdominal surgical wound dehiscence that requires secondary closure. The participants will receive a weekly application of ActiGraft for 4 weeks, or until complete healing of the wound (the earlier of the two). An historic matched-control group of 20 patients will be compared retrospectively
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Whole blood clot (WBC) gel
Meir Medical Center
Kfar Saba, Israel
RECRUITINGIncidence of complete wound closure
Skin re-epithelialization without drainage or dressing requirements
Time frame: 4 weeks
Wound Percent Area Reduction (PAR)
The change in wound area (decrease or increase) with respect to the area at baseline, expressed as a percentage.
Time frame: 2, 4 and 6 weeks
Mean time of complete wound closure
Skin re-epithelialization without drainage or dressing requirements
Time frame: 4 weeks
Durability of wound closure 2 weeks after complete healing
No wound dehiscence
Time frame: Up to 6 weeks
Comparison of time to complete closure between study cases and historic control
Skin re-epithelialization without drainage or dressing requirements
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.